Tanvi Gupta

Ms. Tanvi Gupta

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AVAnupama Vadhan
Anupama Vadhan
TGTanvi Gupta
Tanvi Gupta
Wen-Li HsuWen-Li Hsu
Wen-Li Hsu
Osteoarthritis (OA) is a leading cause of pain and disability worldwide in elderly people. There is a critical need to develop novel therapeutic strategies that can effectively manage pain and disability to improve the quality of life for older people. Mesenchymal stem cells (MSCs) have emerged as a promising cell-based therapy for age-related disorders due to their multilineage differentiation and strong paracrine effects. Notably, MSC-derived exosomes (MSC-Exos) have gained significant attention because they can recapitulate MSCs into therapeutic benefits without causing any associated risks compared with direct cell transplantation. These exosomes help in the transport of bioactive molecules such as proteins, lipids, and nucleic acids, which can influence various cellular processes related to tissue repair, regeneration, and immune regulation. In this review, we have provided an overview of MSC-Exos as a considerable treatment option for osteoarthritis. This review will go over the underlying mechanisms by which MSC-Exos may alleviate the pathological hallmarks of OA, such as cartilage degradation, synovial inflammation, and subchondral bone changes. Furthermore, we have summarized the current preclinical evidence and highlighted promising results from in vitro and in vivo studies, as well as progress in clinical trials using MSC-Exos to treat OA.

21 February 2025 in Progress in Biophysics and Molecular Biology
Verified
Journal Article
Closed access
TGTanvi Gupta
Tanvi Gupta
MMMohd Murtaza
Mohd Murtaza

2 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
TGTanvi Gupta
Tanvi Gupta
Tilahun Ayane DebeleTilahun Ayane Debele
Tilahun Ayane Debele
YWYu-Feng Wei
Yu-Feng Wei
AGAnish Gupta
Anish Gupta
MMMohd Murtaza
Mohd Murtaza
WSWen-Pin Su
Wen-Pin Su
Since 2019, the SARS-CoV-2 pandemic has caused a huge chaos throughout the world and the major threat has been possessed by the immune-compromised individuals involving the cancer patients; their weakened immune response makes them vulnerable and susceptible to the virus. The oncologists as well as their patients are facing many problems for their treatment sessions as they need to postpone their surgery, chemotherapy, or radiotherapy. The approach that could be adopted especially for the cancer patients is the amalgamation of immunotherapy and nanotherapy which can reduce the burden on the healthcare at this peak time of the infection. There is also a need to predict or analyze the data of cancer patients who are at a severe risk of being exposed to an infection in order to reduce the mortality rate. The use of artificial intelligence (AI) could be incorporated where the real time data will be available to the physicians according to the different patient’s clinical characteristics and their past treatments. With this data, it will become easier for them to modify or replace the treatment to increase the efficacy against the infection. The combination of an immunotherapy and nanotherapy will be targeted to treat the cancer patients diagnosed with SARS-CoV-2 and the AI will act as icing on the cake to monitor, predict and analyze the data of the patients to improve the treatment regime for the most vulnerable patients.

9 March 2022 in Eurasian Journal of Medicine and Oncology
Verified
Journal Article
Closed access
PDF file
TGTanvi Gupta
Tanvi Gupta
MMMohd Murtaza
Mohd Murtaza
MGMrinmoy Ghosh
Mrinmoy Ghosh
WSWen Pin Su
Wen Pin Su
NPNarendra Kumar Pandey
Narendra Kumar Pandey
UGUmesh Goutam
Umesh Goutam
The disease that poses a major threat to human life is cancer. Although different treatment techniques such as chemotherapy, radiotherapy, and chemically driven drugs are used, they do not show expected results and cause many side effects, eventually leading to the death of patients. However, there is one approach that is promising is the consolidation of cancer vaccines and immunotherapy, in which tumor-specific antigens, tumor-associated antigens, antigen-presenting cells, and toll-like receptors play a major role. The approach involves vaccines that are approved by the FDA and has shown good results in the latest research studies.

30 June 2021 in Annals of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Closed access
PDF file
TGTanvi Gupta
Tanvi Gupta
WSWen-Pin Su
Wen-Pin Su
Tanvi GUPTA, Wen-Pin SU*. Ann Hepatobiliary Pancreat Surg 2021;25:S381. https://doi.org/10.14701/ahbps.EP-182

2 January 2026
Verified
Book Chapter
Closed access
PDF file
TGTanvi Gupta
Tanvi Gupta
MMMohd Murtaza
Mohd Murtaza